As part of Ohio’s ongoing effort to mitigate the impact of opiate abuse, the Kasich Administration announced plans to address the epidemic among the smallest of individuals – babies born to mothers who are addicted to opiate painkillers and heroin. The Maternal Opiate Medical Support (M.O.M.S.) Project will improve health outcomes and reduce costs associated with extended hospital stays by neutralizing the impact of Neonatal Abstinence Syndrome (NAS). NAS is a complex disorder with a myriad of possible symptoms found in newborns and caused by exposure to addictive illegal or prescription drugs.
The most common conditions associated with NAS are withdrawal, respiratory complications, low birth weight, feeding difficulties and seizures. Treating newborns impacted by NAS was associated with more than $70 million in healthcare expenses and nearly 19,000 days in Ohio’s hospitals in 2011, according to data from the Ohio Hospital Association.
Under the leadership of the Governor’s Office of Health Transformation, OhioMHAS and the Ohio Departments of Health and Medicaid, the M.O.M.S. Project will support interventions and prenatal treatments that improve outcomes for 200 women and babies while reducing the cost of specialized care by shortening length of stay in Neo-Natal Intensive Care Units (NICU). By engaging expecting mothers in a combination of counseling, Medication-Assisted Treatment (MAT) and case management, the three-year project is estimated to reduce infant hospital stays by 30 percent.
Read the press release for complete information.